Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo

Iawen Hsu, Chiuan Ren Yeh, Spencer Slavin, Hiroshi Miyamoto, George J. Netto, Yu Chieh Tsai, Mesut Muyan, Xue Ru Wu, Edward M. Messing, Elizabeth A. Guancial, Shuyuan Yeh

Research output: Contribution to journalArticle

Abstract

Clinical reports show males have a higher bladder cancer (BCa) incidence than females. The sexual difference of BCa occurrence suggests that estrogen and its receptors may affect BCa development. Estrogen receptor alpha (ERa) is the classic receptor to convey estrogen signaling, however, the function of ERa in BCa development remains largely unknown. To understand the in vivo role of ERa in BCa development, we generated total and urothelial specific ERa knockout mice (ERaKO) and used the pre-carcinogen BBN to induce BCa. Earlier reports showed that ERa promotes breast and ovarian cancers in females. Surprisingly and of clinical importance, our results showed that ERa inhibits BCa development and loss of the ERa gene results in an earlier onset and higher incidence of BBN-induced in vivo mouse BCa. Supportively, carcinogen induced malignant transformation ability was reduced in ERa expressing urothelial cells as compared to ERa negative cells. Mechanism studies suggest that ERa could control the expression of INPP4B to reduce AKT activity and consequently reduce BCa cell growth. In addition, IHC staining of clinical sample analyses show that INPP4B expression, in correlation with reduced ERa, is significantly reduced in human BCa specimens. Together, this is the first report using the in vivo cre-loxP gene knockout mouse model to characterize ERa roles in BCa development. Our studies provide multiple in vitro cell studies and in vivo animal model data as well as human BCa tissue analyses to prove ERa plays a protective role in BCa initiation and growth at least partly via modulating the INPP4B/Akt pathway.

Original languageEnglish (US)
Pages (from-to)7917-7935
Number of pages19
JournalOncotarget
Volume5
Issue number17
StatePublished - 2014

Fingerprint

Estrogen Receptor alpha
Urinary Bladder Neoplasms
Knockout Mice
Carcinogens
In Vitro Techniques
Gene Knockout Techniques
Incidence
Growth
Estrogen Receptors
Ovarian Neoplasms
Estrogens
Animal Models

ASJC Scopus subject areas

  • Oncology

Cite this

Hsu, I., Yeh, C. R., Slavin, S., Miyamoto, H., Netto, G. J., Tsai, Y. C., ... Yeh, S. (2014). Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo. Oncotarget, 5(17), 7917-7935.

Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo. / Hsu, Iawen; Yeh, Chiuan Ren; Slavin, Spencer; Miyamoto, Hiroshi; Netto, George J.; Tsai, Yu Chieh; Muyan, Mesut; Wu, Xue Ru; Messing, Edward M.; Guancial, Elizabeth A.; Yeh, Shuyuan.

In: Oncotarget, Vol. 5, No. 17, 2014, p. 7917-7935.

Research output: Contribution to journalArticle

Hsu, I, Yeh, CR, Slavin, S, Miyamoto, H, Netto, GJ, Tsai, YC, Muyan, M, Wu, XR, Messing, EM, Guancial, EA & Yeh, S 2014, 'Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo', Oncotarget, vol. 5, no. 17, pp. 7917-7935.
Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ, Tsai YC et al. Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo. Oncotarget. 2014;5(17):7917-7935.
Hsu, Iawen ; Yeh, Chiuan Ren ; Slavin, Spencer ; Miyamoto, Hiroshi ; Netto, George J. ; Tsai, Yu Chieh ; Muyan, Mesut ; Wu, Xue Ru ; Messing, Edward M. ; Guancial, Elizabeth A. ; Yeh, Shuyuan. / Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo. In: Oncotarget. 2014 ; Vol. 5, No. 17. pp. 7917-7935.
@article{e38076189ddb42aa8cb1fd5b272371fd,
title = "Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo",
abstract = "Clinical reports show males have a higher bladder cancer (BCa) incidence than females. The sexual difference of BCa occurrence suggests that estrogen and its receptors may affect BCa development. Estrogen receptor alpha (ERa) is the classic receptor to convey estrogen signaling, however, the function of ERa in BCa development remains largely unknown. To understand the in vivo role of ERa in BCa development, we generated total and urothelial specific ERa knockout mice (ERaKO) and used the pre-carcinogen BBN to induce BCa. Earlier reports showed that ERa promotes breast and ovarian cancers in females. Surprisingly and of clinical importance, our results showed that ERa inhibits BCa development and loss of the ERa gene results in an earlier onset and higher incidence of BBN-induced in vivo mouse BCa. Supportively, carcinogen induced malignant transformation ability was reduced in ERa expressing urothelial cells as compared to ERa negative cells. Mechanism studies suggest that ERa could control the expression of INPP4B to reduce AKT activity and consequently reduce BCa cell growth. In addition, IHC staining of clinical sample analyses show that INPP4B expression, in correlation with reduced ERa, is significantly reduced in human BCa specimens. Together, this is the first report using the in vivo cre-loxP gene knockout mouse model to characterize ERa roles in BCa development. Our studies provide multiple in vitro cell studies and in vivo animal model data as well as human BCa tissue analyses to prove ERa plays a protective role in BCa initiation and growth at least partly via modulating the INPP4B/Akt pathway.",
author = "Iawen Hsu and Yeh, {Chiuan Ren} and Spencer Slavin and Hiroshi Miyamoto and Netto, {George J.} and Tsai, {Yu Chieh} and Mesut Muyan and Wu, {Xue Ru} and Messing, {Edward M.} and Guancial, {Elizabeth A.} and Shuyuan Yeh",
year = "2014",
language = "English (US)",
volume = "5",
pages = "7917--7935",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "17",

}

TY - JOUR

T1 - Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo

AU - Hsu, Iawen

AU - Yeh, Chiuan Ren

AU - Slavin, Spencer

AU - Miyamoto, Hiroshi

AU - Netto, George J.

AU - Tsai, Yu Chieh

AU - Muyan, Mesut

AU - Wu, Xue Ru

AU - Messing, Edward M.

AU - Guancial, Elizabeth A.

AU - Yeh, Shuyuan

PY - 2014

Y1 - 2014

N2 - Clinical reports show males have a higher bladder cancer (BCa) incidence than females. The sexual difference of BCa occurrence suggests that estrogen and its receptors may affect BCa development. Estrogen receptor alpha (ERa) is the classic receptor to convey estrogen signaling, however, the function of ERa in BCa development remains largely unknown. To understand the in vivo role of ERa in BCa development, we generated total and urothelial specific ERa knockout mice (ERaKO) and used the pre-carcinogen BBN to induce BCa. Earlier reports showed that ERa promotes breast and ovarian cancers in females. Surprisingly and of clinical importance, our results showed that ERa inhibits BCa development and loss of the ERa gene results in an earlier onset and higher incidence of BBN-induced in vivo mouse BCa. Supportively, carcinogen induced malignant transformation ability was reduced in ERa expressing urothelial cells as compared to ERa negative cells. Mechanism studies suggest that ERa could control the expression of INPP4B to reduce AKT activity and consequently reduce BCa cell growth. In addition, IHC staining of clinical sample analyses show that INPP4B expression, in correlation with reduced ERa, is significantly reduced in human BCa specimens. Together, this is the first report using the in vivo cre-loxP gene knockout mouse model to characterize ERa roles in BCa development. Our studies provide multiple in vitro cell studies and in vivo animal model data as well as human BCa tissue analyses to prove ERa plays a protective role in BCa initiation and growth at least partly via modulating the INPP4B/Akt pathway.

AB - Clinical reports show males have a higher bladder cancer (BCa) incidence than females. The sexual difference of BCa occurrence suggests that estrogen and its receptors may affect BCa development. Estrogen receptor alpha (ERa) is the classic receptor to convey estrogen signaling, however, the function of ERa in BCa development remains largely unknown. To understand the in vivo role of ERa in BCa development, we generated total and urothelial specific ERa knockout mice (ERaKO) and used the pre-carcinogen BBN to induce BCa. Earlier reports showed that ERa promotes breast and ovarian cancers in females. Surprisingly and of clinical importance, our results showed that ERa inhibits BCa development and loss of the ERa gene results in an earlier onset and higher incidence of BBN-induced in vivo mouse BCa. Supportively, carcinogen induced malignant transformation ability was reduced in ERa expressing urothelial cells as compared to ERa negative cells. Mechanism studies suggest that ERa could control the expression of INPP4B to reduce AKT activity and consequently reduce BCa cell growth. In addition, IHC staining of clinical sample analyses show that INPP4B expression, in correlation with reduced ERa, is significantly reduced in human BCa specimens. Together, this is the first report using the in vivo cre-loxP gene knockout mouse model to characterize ERa roles in BCa development. Our studies provide multiple in vitro cell studies and in vivo animal model data as well as human BCa tissue analyses to prove ERa plays a protective role in BCa initiation and growth at least partly via modulating the INPP4B/Akt pathway.

UR - http://www.scopus.com/inward/record.url?scp=84907546544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907546544&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 7917

EP - 7935

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 17

ER -